Fear is what stops people from seeking help in the first place.
In Portugal, where two million adults live with obesity and the country ranks among Europe's most affected, a new public health campaign asks a question that cuts deeper than statistics: how much does fear itself cost us? Launched by a coalition of medical societies and patient advocates, 'How Much Does Fear Weigh?' confronts not only the physical burden of a condition linked to over 200 diseases, but the shame and misunderstanding that prevent people from seeking care. It is a reminder that stigma — whether carried by patients, cultures, or the healthcare professionals meant to help — is itself a form of illness, and that societies pay dearly for the treatments they delay.
- Portugal's obesity crisis is quietly compounding: two million adults affected, 67.6% of the population pre-obese, and €1.2 billion drained from healthcare each year — yet fear and shame keep many from ever walking through a doctor's door.
- The campaign's sharpest finding is that stigma lives not only in workplaces and waiting rooms, but inside the medical profession itself, where obesity is still too often dismissed as a failure of willpower rather than treated as a complex chronic disease.
- People living with obesity fear cancer, immobility, and early death — but rarely connect those fears to their weight, leaving the root cause unaddressed while its 200-plus associated conditions quietly accumulate.
- Three organizations and a pharmaceutical partner are pushing back through television, hospitals, pharmacies, and digital platforms, insisting that effective treatment exists across three pillars — behavioral change, medication, and surgery — and that early intervention through family doctors is both possible and urgent.
- Policymakers are being handed a stark economic argument: the cost of treating obesity today is a fraction of the cost of managing the diabetes, cardiovascular disease, and cancer that follow when it goes untreated.
Portugal has launched a public health campaign called 'How Much Does Fear Weigh?' to address what medical professionals describe as a long-neglected crisis — not just the physical toll of obesity, but the psychological and cultural barriers that prevent people from confronting it. Appearing on television, in hospitals and pharmacies, and across digital platforms, the campaign was developed jointly by the Portuguese Association of People Living with Obesity, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society for the Study of Obesity, with pharmaceutical support from Novo Nordisk.
Paula Freitas, president of the endocrinology society, captures the campaign's central paradox: a person living with obesity may deeply fear not living long enough to raise their children, and separately fear cancer — yet never connect either fear to their weight. This disconnect, she argues, is compounded by stigma that runs through every layer of society, including among healthcare professionals who still reduce obesity to a question of diet and exercise, obscuring its complexity as a chronic medical condition.
The statistics frame the urgency. Portugal ranks third worst in Europe for obesity prevalence. Two million adults are affected, nearly 68% of the population is pre-obese, and the direct annual cost reaches €1.2 billion — nearly 6% of all healthcare spending. Beyond those figures lie workplace discrimination, lost income, rising disability, and shortened lives.
Freitas is clear that treatment works. Obesity care rests on three pillars — behavioral change, medication, and surgery — and most patients will draw on all three at different moments. The campaign's call to action is directed both at individuals and at policymakers: engage early, through family doctors when possible, and recognize that the cost of prevention today is far smaller than the cost of treating the cascade of diseases that follow when obesity goes unaddressed. The question the campaign poses is not rhetorical. It asks Portuguese society to name what stands between people and the help they need — and to understand that fear, shame, and stigma are obstacles medicine already knows how to move.
Portugal has launched a campaign called "How Much Does Fear Weigh?" designed to confront one of the country's most pressing health crises: the psychological and medical weight of obesity. The initiative, which will appear on television, in hospitals and pharmacies, and across digital platforms, targets a fundamental problem that medical professionals say has been overlooked for too long—the disconnect between what people fear and what they actually understand about their own bodies.
Paula Freitas, president of the Portuguese Society of Endocrinology, Diabetes and Metabolism, frames the campaign's central insight with a personal example: someone living with obesity might fear not living long enough to raise their children, yet that same person may dread cancer without ever connecting it to their weight. The disconnect runs deeper still. People worry about physical limitation and loss of mobility, but few recognize that obesity sits at the root of more than 200 associated diseases and conditions. The campaign's core message is that understanding these fears—and the shame that often accompanies them—is essential to treating obesity as the chronic disease it is.
The stigma surrounding obesity runs through every layer of Portuguese society. It lives in the minds of people struggling with their weight. It persists in the broader culture. And, Freitas notes with particular concern, it persists among healthcare professionals themselves, many of whom still treat obesity as a simple matter of eating less and moving more. This reductive view obscures the reality that obesity is a complex medical condition requiring serious intervention. The campaign is a joint effort of three organizations: the Portuguese Association of People Living with Obesity, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society for the Study of Obesity, with support from pharmaceutical company Novo Nordisk.
The numbers tell a stark story. Portugal ranks third worst in Europe for obesity prevalence. Approximately two million adults currently live with obesity, and 67.6 percent of the population is classified as pre-obese. Chronic diseases account for 86 percent of the overall disease burden in the country. The direct costs of obesity alone reach roughly 1.2 billion euros annually—equivalent to 0.6 percent of Portugal's GDP and 5.8 percent of all healthcare spending. But the financial toll extends far beyond direct medical expenses. People living with obesity face workplace discrimination, lose income through increased absenteeism, and accumulate disability from the cascade of diseases that follow.
Freitas emphasizes that treatment exists and works. Obesity management rests on three pillars: behavioral change, medication, and surgery. For some patients, surgery is the first and only viable option. For others, medication offers effective relief with good tolerability and safety profiles. Still others benefit primarily from behavioral intervention. Most people will need all three approaches at different points in their lives. The key is early intervention—catching obesity before the 200-plus associated conditions take hold. Family doctors, she argues, should be the first point of contact. Many are already equipped to treat obesity directly; those who are not can refer patients to hospital-based medical or surgical care.
Freitas frames the economic argument for prevention with clarity: treating obesity now may seem expensive, but failing to treat it guarantees far costlier interventions later, when patients arrive with diabetes, hypertension, cardiovascular disease, and cancer. The campaign's central challenge to policymakers is simple but urgent: understand that prevention today saves vastly more than treatment tomorrow. The question "How Much Does Fear Weigh?" is not rhetorical. It asks Portuguese society to measure what stands between people and the medical help they need—and to recognize that fear, shame, and stigma are obstacles that can be removed.
Citas Notables
If someone has obesity, I fear not living long enough to raise my children. But many people fear cancer and never connect it to obesity.— Paula Freitas, president of the Portuguese Society of Endocrinology, Diabetes and Metabolism
The challenge is simple but urgent: do not let fear weigh more than the decision to seek medical support.— Campaign organizers
La Conversación del Hearth Otra perspectiva de la historia
Why does a campaign about obesity need to focus on fear rather than, say, nutrition or exercise?
Because fear is what stops people from seeking help in the first place. Someone might know they need to see a doctor, but shame and the stigma they've internalized—or that they've experienced from others—keeps them away. The campaign is trying to name that barrier.
You mentioned that healthcare professionals themselves carry this stigma. How does a doctor's bias affect a patient?
If a doctor sees obesity as a personal failure rather than a disease, they're less likely to take it seriously, less likely to offer real treatment options, and more likely to dismiss the patient's concerns. That reinforces the shame the patient already feels. It becomes a closed loop.
The campaign mentions 200 diseases linked to obesity. That seems like an exaggeration.
It's not. Obesity is connected to cancer, heart disease, diabetes, stroke, arthritis, sleep apnea, depression, infertility—the list is genuinely long. Most people don't make those connections. They fear cancer but don't realize their weight increases their cancer risk. That's the gap the campaign is trying to close.
If treatment exists and works, why is Portugal's obesity rate so high?
Because knowing treatment exists and actually accessing it are different things. There's the stigma barrier. There's the cost barrier. There's the barrier of not knowing where to start. And there's the barrier of a healthcare system that hasn't always treated obesity as a serious medical priority.
What does early intervention actually mean in practical terms?
It means catching someone at pre-obesity, or at the earliest stages of obesity, before they develop diabetes or heart disease or the other conditions that make treatment much harder and more expensive. It means a family doctor having a conversation about weight as a health issue, not a character issue.
The economic argument—1.2 billion euros in direct costs—that's a lot. Does that number move policymakers?
It should. But there's also the indirect cost: lost productivity, workplace discrimination, people unable to work at all. The real number is much higher. The campaign is essentially saying: you can pay now or pay much more later. Prevention is cheaper.